REUTERS - Swiss pharmaceutical manufacturer Lonza Group AG on Monday confirmed it is in advanced talks with private equity firm KKR & Co LP to acquire Capsugel, a U.S. maker of capsule products and ...

Xcelience provides the company with specialized clinical trial manufacturing and supply capabilities for a broad range of solid dosage forms Powdersize brings micronization capabilities that augment ...

Private equity firm KKR will buy Pfizer’s Capsugel business for $2.375 billion in cash, the firms revealed Monday morning in a joint statement. Capsugel generated about $750 million in revenue in 2010 ...

Lonza Group, a Swiss chemicals and biotechnology company, will acquire Capsugel for $5.5 billion, reports Reuters. Here are four things to know about the deal. 1. Capsugel, based in Morristown, N.J., ...

Capsugel Investing More Than $25 Million in Increased Production Capacity and Quality Enhancements for its Industry-Leading Vegetarian Capsule Portfolio Morristown, N.J., March 26, 2015 – Capsugel, a ...

Capsugel plans to acquire Bend Research to enhance its bioavailability-enhancement capabilities. Seeking to build its bioavailability-enhancement capabilities, Capsugel, a provider of capsules and ...

NEW YORK -- Pfizer Inc. said Monday it will sell its Capsugel capsule-making business to private equity firm Kohlberg Kravis Robert & Co. for $2.38 billion in cash. In October, Pfizer said it would ...

I was going to title this post "Big or Small We Track Them All" but on second thought it seemed too wordy and just a little bit confusing. Pharmaceutical giant Pfizer (PFE) announced today that it is ...

Pfizer Inc., the world’s biggest drugmaker, agreed to sell its Capsugel manufacturing unit to KKR & Co. for $2.38 billion in an effort to focus on its higher-profit business developing new medicines.

Capsugel adds clinical trial and commercial manufacturing, as well as particle engineering services with two acquisitions. In the latest development in a busy year of mergers and acquisitions in the ...

Capsugel and Bend Research have announced that they have entered into a definitive agreement for Capsugel to acquire Bend Research as part of its Dosage Form Solutions (DFS) business unit. The ...